This continuing multifaceted University of Arizona (DA) short-term Medical Student Research Program (MSRP) seeks to introduce, train and nurture inquiring medical students in basic and clinical medical research;and further, to provide the stimulus for subsequent intensive and extensive research experiences. Building on the past 25 years of high level participation, esprit-de-corps, and outstanding trainee productivity (research presentations, publications, awards, and advanced research), full-time opportunities for summer/ vacation laboratory and clinical investigation will be offered under experienced faculty mentors predominantly concentrated in Specialized Centers of Excellence focusing on in vivo, in vitro, in situ, in silico and modeling approaches to the cardiovascular system and its disorders (e.g. heart failure, developmental abnormalities, cardiac arrest/resuscitation, transplantation, artificial hearts, lymphedema-angiodysplasia syndromes);cancer (e.g., prevention, epidemiology, detection, pharmacogenomics, drug development);neurosciences (e.g., cognition, molecular psychiatry, neurotransmitters, drug addiction, neural regeneration), and a variety of other areas spanning the full spectrum of research topics in children, adults and special populations so as to capture the individual interests and talents of medical students. The research experience will be integrated into an innovative Curriculum on Medical Ignorance (CMI), concentrated in a Summer Institute and complemented by a menu of year-round trainee-related activities (seminars and workshops, clinical correlations, advanced extracurricular research through a student-initiated Research Honors Distinction Track, visiting professorships, "thriving" workshops, and career advising), open to all medical students.
CMI aims to foster attitudes and skills to recognize and deal with the vast shifting world of medical ignorance ["what we know we don't know (current research), don't know we don't know (future discovery), and think we know but don't (error)"] from molecular to clinical medicine. Detailed short-term and long-term formative and summative evaluation of the program and participants, including database registry, individual development plans, and career portfolios, will be continued to document effectiveness and promote networking.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
NRSA Short -Term Research Training (T35)
Project #
5T35HL007479-30
Application #
8461959
Study Section
Special Emphasis Panel (ZHL1-CSR-K (O1))
Program Officer
Meadows, Tawanna
Project Start
1981-05-01
Project End
2014-04-30
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
30
Fiscal Year
2013
Total Cost
$184,074
Indirect Cost
$13,641
Name
University of Arizona
Department
Surgery
Type
Schools of Medicine
DUNS #
806345617
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Luber, Adam J; Tsui, Cindy L; Heinecke, Gillian M et al. (2014) Long-term durability and dose escalation patterns in infliximab therapy for psoriasis. J Am Acad Dermatol 70:525-32
Yue, X; Hariri, D J; Caballero, B et al. (2014) Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease. Neuroscience 258:385-400
Gruessner, Christine; Gruessner, Angelika; Glaser, Katherine et al. (2014) Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence. Cancer Prev Res (Phila) 7:896-905
Melemedjian, Ohannes K; Tillu, Dipti V; Asiedu, Marina N et al. (2013) BDNF regulates atypical PKC at spinal synapses to initiate and maintain a centralized chronic pain state. Mol Pain 9:12
Sakles, John C; Kalin, Leah (2012) The effect of stylet choice on the success rate of intubation using the GlideScope video laryngoscope in the emergency department. Acad Emerg Med 19:235-8
Melemedjian, Ohannes K; Asiedu, Marina N; Tillu, Dipti V et al. (2011) Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain. Mol Pain 7:70
Bomprezzi, R; Schafer, R; Reese, V et al. (2011) Glatiramer acetate-specific antibody titres in patients with relapsingýýý/ýýýremitting multiple sclerosis and in experimental autoimmune encephalomyelitis. Scand J Immunol 74:219-26
Witte, Marlys H (2011) Translational/personalized medicine, pharmaco/surgico/radiogenomics, lymphatic spread of cancer, and medical ignoromes. J Surg Oncol 103:501-7
Witte, Marlys H; Dellinger, Michael T; McDonald, Donald M et al. (2011) Lymphangiogenesis and hemangiogenesis: potential targets for therapy. J Surg Oncol 103:489-500
Melemedjian, Ohannes K; Asiedu, Marina N; Tillu, Dipti V et al. (2010) IL-6- and NGF-induced rapid control of protein synthesis and nociceptive plasticity via convergent signaling to the eIF4F complex. J Neurosci 30:15113-23

Showing the most recent 10 out of 46 publications